Serum lipids in an ambulary diabetic clientele. Effect of therapy with Atromidin (clofibrate).
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000150:complications; D001786:Blood Glucose / Q000032:analysis; D002784:Cholesterol / Q000097:blood*; D002994:Clofibrate / Q000627:therapeutic use; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000097:blood*; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000097:blood; D011422:Propionates / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood*
D000924:Anticholesteremic Agents; D001786:Blood Glucose; D011422:Propionates; D014280:Triglycerides; D002784:Cholesterol; D002994:Clofibrate